{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:38:37Z","timestamp":1790545117304,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.atherosclerosis.2017.06.019","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T19:00:33Z","timestamp":1496948433000},"page":"108-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes"],"prefix":"10.1016","volume":"264","author":[{"given":"Ayman","family":"Samman Tahhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0180-349X","authenticated-orcid":false,"given":"Salim S.","family":"Hayek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Sandesara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Hajjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hammadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley T.","family":"O'Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heval M.","family":"Kelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9437-1301","authenticated-orcid":false,"given":"Ayman","family":"Alkhoder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Ghasemzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-An","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Aida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Mazen","family":"Gafeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Abdelhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem Hosny","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipra","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Vaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshed","family":"Quyyumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib1","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circulation Res."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Ankle Brachial Index","year":"2008","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.06.019_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrcardio.2016.179","article-title":"Peripheral artery disease: epidemiology and global perspectives","volume":"14","author":"Fowkes","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.06.019_bib5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1373\/clinchem.2016.263798","article-title":"Biomarkers and genetics in peripheral artery disease","volume":"63","author":"Hazarika","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/CIRCRESAHA.116.308802","article-title":"Circulating progenitor cells identify peripheral arterial disease in patients with coronary artery disease","volume":"119","author":"Hayek","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib7","doi-asserted-by":"crossref","first-page":"e001118","DOI":"10.1161\/JAHA.114.001118","article-title":"Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events","volume":"3","author":"Eapen","year":"2014","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib8","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","volume":"373","author":"Hayek","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib9","first-page":"502","article-title":"Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD","volume":"220","author":"Persson","year":"2012","journal-title":"Results Malmo Diet Cancer Study. Atheroscler."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib10","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1161\/STROKEAHA.112.664094","article-title":"Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque","volume":"43","author":"Edsfeldt","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib11","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood-2004-06-2424","article-title":"Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization","volume":"105","author":"Selleri","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.it.2004.06.004","article-title":"uPA and uPAR in fibrinolysis, immunity and pathology","volume":"25","author":"Mondino","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib13","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.4049\/jimmunol.168.7.3507","article-title":"Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia","volume":"168","author":"Rijneveld","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.03.072","article-title":"Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomes","volume":"62","author":"Eapen","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/HJR.0b013e328308bb8b","article-title":"C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study","volume":"15","author":"Jeppesen","year":"2008","journal-title":"Eur. J. Cardiovasc Prev. Rehabil."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1182\/blood-2008-12-193524","article-title":"Participation of the urokinase receptor in neutrophil efferocytosis","volume":"114","author":"Park","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib17","doi-asserted-by":"crossref","first-page":"R270","DOI":"10.1186\/cc10550","article-title":"Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort study","volume":"15","author":"Backes","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1055\/s-0037-1616105","article-title":"Release of soluble urokinase receptor from vascular cells","volume":"86","author":"Chavakis","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib19","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.cjca.2016.04.012","article-title":"SuPAR predicts cardiovascular events and mortality in patients with asymptomatic aortic stenosis","volume":"32","author":"Hodges","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2011.01.049","article-title":"Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events","volume":"216","author":"Sehestedt","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/STROKEAHA.113.003305","article-title":"Soluble urokinase plasminogen activator receptor: a risk factor for carotid plaque, stroke, and coronary artery disease","volume":"45","author":"Persson","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2014.12.025","article-title":"Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease","volume":"239","author":"Mekonnen","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2014.08.035","article-title":"Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects","volume":"237","author":"Sorensen","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2215\/CJN.07290714","article-title":"Biomarkers of kidney injury and klotho in patients with atherosclerotic renovascular disease","volume":"10","author":"Park","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/hr.2015.22","article-title":"Soluble urokinase plasminogen activator receptor and hypertension among black South Africans after 5 years","volume":"38","author":"Botha","year":"2015","journal-title":"Hypertens. Res. Off. J. Jpn. Soc. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/eci.12278","article-title":"Associations of suPAR with lifestyle and cardiometabolic risk factors","volume":"44","author":"Botha","year":"2014","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.mbc.0000114441.59147.56","article-title":"Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions","volume":"15","author":"Steins","year":"2004","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","article-title":"uPAR: a versatile signalling orchestrator","volume":"3","author":"Blasi","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/stem.150398","article-title":"Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR","volume":"15","author":"Plesner","year":"1997","journal-title":"Stem Cells"},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2011.10.044","article-title":"The urokinase system in the pathogenesis of atherosclerosis","volume":"222","author":"Fuhrman","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jvs.2014.06.116","article-title":"Association of monocyte tumor necrosis factor alpha expression and serum inflammatory biomarkers with walking impairment in peripheral artery disease","volume":"61","author":"Pande","year":"2015","journal-title":"J.\u00a0Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jvs.2005.03.025","article-title":"Inflammatory mediators are associated with 1-year mortality in critical limb ischemia","volume":"42","author":"Barani","year":"2005","journal-title":"J.\u00a0Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib33","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1161\/ATVBAHA.113.301736","article-title":"C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study","volume":"33","author":"van Wijk","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.06.019_bib34","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.3390\/ijms160511294","article-title":"A\u00a0review of the pathophysiology and potential biomarkers for peripheral artery disease","volume":"16","author":"Krishna","year":"2015","journal-title":"Int. J. Mol. Sci."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017302691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017302691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T16:29:06Z","timestamp":1569428946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017302691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":34,"alternative-id":["S0021915017302691"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.06.019","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}